Inicio › Linfoma de Burkitt › Maryland › Baltimore
Ensayos clínicos de Linfoma de Burkitt en Baltimore, MD
8 estudios para Linfoma de Burkitt buscan participantes en centros de Baltimore y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
ReclutandoFase 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
ReclutandoFase 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 1
- University of Maryland, Baltimore
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
ReclutandoFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
ReclutandoFase 2
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
ReclutandoFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
ReclutandoFase 1
- University of Maryland, Baltimore
Ensayos de Linfoma de Burkitt en otras ciudades
- Houston, TX21 estudios
- Milwaukee, WI16 estudios
- Philadelphia, PA16 estudios
- New York City, NY14 estudios
- Chicago, IL13 estudios
- Cincinnati, OH12 estudios
- Seattle, WA12 estudios
- Atlanta, GA11 estudios
- Boston, MA10 estudios
- Los Angeles, CA10 estudios
- Durham, NC10 estudios
- Kansas City, MO10 estudios
Otros estudios en Baltimore
- Cáncer de pulmón de células no pequeñas60 estudios
- Cáncer de seno47 estudios
- Cáncer de próstata42 estudios
- Cáncer de pulmón40 estudios
- Cáncer (todos los tipos)38 estudios
- Cáncer de páncreas32 estudios
- Cáncer del colon y del recto31 estudios
- Cáncer metastásico28 estudios
- Obesidad25 estudios
- Cáncer de vejiga24 estudios
- Fallo cardíaco24 estudios
- Accidente cerebrovascular22 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.